Cronos Group Inc.
CRONNasdaqHealthcare · Medicinal Chemicals & Botanical Products · A1 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $146.6M | $117.6M | $87.2M | $86.7M | $64.6M | $46.7M |
| Operating income | −$17.4M | −$76.5M | −$84.8M | −$111.4M | −$292.0M | −$219.4M |
| Net income | −$9.4M | $41.1M | −$74.0M | −$168.7M | −$396.1M | −$73.1M |
| Total assets | $1.20B | $1.17B | $1.14B | $1.21B | $1.40B | $1.93B |
| Total liabilities | $54.2M | $55.3M | $44.1M | $72.0M | $63.5M | $217.5M |
| Equity | $1.09B | $1.06B | $1.10B | $1.14B | $1.34B | $1.71B |
| EPS (diluted) | $-0.02 | $0.11 | $-0.19 | $-0.45 | $-1.07 | $-0.21 |
| Shares out. | 382.5M | 381.3M | 380.6M | 375.0M | 360.3M | 360.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −11.9%
- Net margin
- −6.4%
- Return on equity
- −0.9%
- Return on assets
- −0.8%
- Return on capital (ROCE)
- −1.5%
- Liabilities / assets
- 4.5%
- Debt / equity
- 0.05×
- Book value / share
- $2.86
- Revenue growth (YoY)
- 24.6%
- Net income growth (YoY)
- −123.0%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 27.23safe
- Accruals / assets
- −2.9%clean
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 2 warning● 5 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Q/Amissed a reporting deadline ↗Feb 18, 2022
- NT 10-Qmissed a reporting deadline ↗Nov 9, 2021
- NT 10-Kmissed a reporting deadline ↗Mar 2, 2020
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Doucet Terrence Gregory JosephOfficer — See Remarks | May 12, 2026 | Option exercise | 10,597 | $0.00 |
| Wagner AdamOfficer — See remarks | May 12, 2026 | Option exercise | 10,367 | $0.00 |
| Buggy ShannonOfficer — See Remarks | May 12, 2026 | Option exercise | 20,622 | $0.00 |
| Kenost Jared MatthewOfficer — See Remarks | May 12, 2026 | Option exercise | 9,412 | $0.00 |
| Weigensberg AryeOfficer — See Remarks | May 10, 2026 | Option exercise | 3,118 | $0.00 |
| Wagner AdamOfficer — See remarks | May 10, 2026 | Option exercise | 10,063 | $0.00 |
| Kenost Jared MatthewOfficer — See Remarks | May 10, 2026 | Option exercise | 7,535 | $0.00 |
| Shlimak AnnaOfficer — See Remarks | Mar 19, 2026 | Option exercise | 28,429 | $0.00 |
| Doucet Terrence Gregory JosephOfficer — See Remarks | Mar 15, 2026 | Option exercise | 23,897 | $0.00 |
| Weigensberg AryeOfficer — See Remarks | Mar 15, 2026 | Option exercise | 24,236 | $0.00 |
| Gorenstein Michael RyanOfficer — See remarks below | Mar 15, 2026 | Option exercise | 324,540 | $0.00 |
| Shlimak AnnaOfficer — See Remarks | Mar 15, 2026 | Option exercise | 45,226 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 4.0M | 2.3 | -9.6% |
| Apr 30, 2026 | 4.4M | 1.6 | -2.6% |
| Apr 15, 2026 | 4.6M | 5.3 | +19.1% |
| Mar 31, 2026 | 3.8M | 4.0 | -7.9% |
| Mar 13, 2026 | 4.2M | 3.8 | +8.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Results of operations · Other material eventMay 11, 2026
- Results of operationsFeb 26, 2026
- Entered a material agreement · Regulation FD disclosureDec 9, 2025
- Results of operationsNov 6, 2025
- Director / officer changeAug 29, 2025
- Results of operations · Director / officer changeAug 7, 2025
- Shareholder voteJun 24, 2025
- Results of operations · Other material eventMay 8, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.